Yunnan Baiyao Group Co.,Ltd (SHE: 000538)

Market Cap	103.58B
Revenue (ttm)	39.34B
Net Income (ttm)	4.30B
Shares Out	1.78B
EPS (ttm)	2.40
PE Ratio	24.18
Forward PE	20.28
Dividend	2.08 (3.46%)
Ex-Dividend Date	Nov 25, 2024

Volume	7,656,641
Open	59.50
Previous Close	60.43
Day's Range	59.50 - 60.65
52-Week Range	44.88 - 67.10
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 1, 2025

About Yunnan Baiyao Group Co.,Ltd

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally. It provides health products; drugs; medical devices; traditional Chinese medicine resources; and tea products. The company also supplies and distributes medicines. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1902
• Employees: 8,834
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000538

Financial Performance

In 2023, Yunnan Baiyao Group Co.,Ltd's revenue was 39.11 billion, an increase of 7.19% compared to the previous year's 36.49 billion. Earnings were 4.09 billion, an increase of 36.41%.